- Home
- KROS vs AEVA Comparison
KROS vs AEVA Comparison
Compare KROS & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | AEVA |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 766.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | AEVA |
|---|---|---|
| Price | $17.73 | $18.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $22.20 | ★ $26.50 |
| AVG Volume (30 Days) | 597.1K | ★ 1.6M |
| Earning Date | 02-25-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $246,718,000.00 | $15,154,000.00 |
| Revenue This Year | $6,924.79 | $87.44 |
| Revenue Next Year | N/A | $70.13 |
| P/E Ratio | $11.38 | ★ N/A |
| Revenue Growth | ★ 37798.31 | 89.90 |
| 52 Week Low | $9.12 | $2.52 |
| 52 Week High | $22.55 | $38.80 |
Technical Indicators
Market Signals| Indicator | KROS | AEVA |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 68.39 |
| Support Level | $19.76 | $12.30 |
| Resistance Level | $21.76 | $13.66 |
| Average True Range (ATR) | 0.81 | 1.06 |
| MACD | -0.54 | 0.19 |
| Stochastic Oscillator | 5.18 | 97.79 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.